Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin in LADA
NCT01159847Phase 2Completed
- Sponsor
- European Foundation for the Study of Diabetes
- Start
- Jan 2010
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sitagliptin in latent autoimmune diabetes in adults (LADA), sponsored by European Foundation for the Study of Diabetes. Started Jan 2010; status: completed.
02
Drugs
sitagliptin
03
Conditions
latent autoimmune diabetes in adults (LADA)
Beyond the preview
Go deeper on NCT01159847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01159847.